Skip to content

Genomadix Cube CYP2C19 System

by Genomadix, Inc.

510(k) K220026

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Abbreviated NumberK220026 Date21 Mar 2023ClearedStatusActive

Official records

From the FDA record

Received by the FDA
5 Jan 2022
FDA decision
21 Mar 2023 (Substantially Equivalent)
FDA review time
440 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K220026 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
NTI
Device class
Class II
Regulation
21 CFR Part 862.3360
Advisory committee
Clinical Toxicology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Genomadix Cube CYP2C19 System is a Drug Metabolizing Enzyme Genotyping System designed for molecular genotyping of the CYP2C19 gene. It automates DNA extraction from buccal samples, PCR amplification, and fluorescence-based detection of CYP2C19 alleles to assess genetic variations linked to drug metabolism.

This system is a portable, sample-to-result thermal cycling instrument intended for use in clinical toxicology settings. Supplied as a single-use or reusable component system (depending on module configuration), it generates results in approximately one hour. The device is FDA 510(k)-cleared under classification II (NTI product code) and operates without MRI restrictions. Storage and handling follow standard molecular diagnostic protocols.

Devices cleared under K220026

5 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K220026
UDI-DISize and differences
Genomadix Cube CYP2C19
Genomadix, Inc.
2G257ASM000960
Single use: no
On the market
Genomadix Cube CYP2C19
Genomadix, Inc.
2G257ASM001160
Single use: yes
On the market
Genomadix Cube CYP2C19
Genomadix, Inc.
2G257ASM000990
Single use: yes
On the market
Genomadix Cube CYP2C19
Genomadix, Inc.
2G257ASM001010
Single use: yes
On the market
Genomadix Cube CYP2C19
Genomadix, Inc.
2G257ASM001030
Single use: yes
On the market

Similar devices

Other devices filed under FDA product code NTI (Drug Metabolizing Enzyme Genotyping Systems).

Other devices from Genomadix, Inc.

See all devices from Genomadix, Inc. →